| Manager | Title | Age | Since |
|---|---|---|---|
Kirk Chin Kee
CEO | Chief Executive Officer | 64 | 2000-02-14 |
Woon Wui Chiew
DFI | Director of Finance/CFO | 52 | 2023-12-31 |
Mei Ling Wong
IRC | Investor Relations Contact | - | 2008-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kirk Chin Kee
CHM | Chairman | 64 | 2010-05-18 |
Robert Millner
BRD | Director/Board Member | 75 | 2000-02-22 |
Kirk Chuen Kee
BRD | Director/Board Member | 61 | 2016-05-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/7/26 | Others | Chief Executive Officer | 5,700,000 | 0.7890% | ||
| 1/7/26 | Others | Chief Executive Officer | 4,035,800 | 0.5586% | ||
| 1/7/26 | Others | Chief Executive Officer | 2,979,372 | 0.4124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 481M | ||
| -1.33% | +4.88% | +54.50% | +109.94% | 1,120B | ||
| -0.69% | -3.77% | +31.35% | +66.62% | 616B | ||
| -0.96% | +0.55% | +23.13% | +94.26% | 504B | ||
| +0.24% | +5.58% | +33.98% | +59.40% | 367B | ||
| -1.59% | -1.25% | +69.39% | +43.02% | 360B | ||
| -0.40% | +3.53% | +19.17% | +46.55% | 288B | ||
| -0.37% | +3.11% | -1.26% | +18.23% | 258B | ||
| -1.75% | +1.76% | +42.21% | +51.44% | 234B | ||
| -2.00% | +1.75% | +24.64% | +95.14% | 194B | ||
| Average | -0.89% | +2.30% | +33.01% | +64.95% | 437.88B | |
| Weighted average by Cap. | -0.99% | +2.42% | +37.90% | +75.52% |
Employees
-
Sector
Pharmaceuticals
















